Sagga, Ramabay .

HRN: 28-75-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/28/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/28/2026
04/03/2026
IV
500mg
Q8
Cholecystits
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: